Free Trial

Aspen Pharmacare (OTCMKTS:APNHY) Sees Strong Trading Volume - What's Next?

Aspen Pharmacare logo with Medical background

Key Points

  • Aspen Pharmacare experienced a significant increase in trading volume, with 3,503 shares traded, marking a 39% rise from the prior session.
  • The company's stock price rose by 2.3%, closing at $5.68, down from a previous close of $5.75.
  • Aspen Pharmacare's financial metrics include a debt-to-equity ratio of 0.36 and a current ratio of 2.35, indicating a solid financial position.
  • Five stocks we like better than Aspen Pharmacare.

Aspen Pharmacare (OTCMKTS:APNHY - Get Free Report) shares saw unusually-strong trading volume on Wednesday . Approximately 3,503 shares were traded during trading, an increase of 39% from the previous session's volume of 2,521 shares.The stock last traded at $5.68 and had previously closed at $5.75.

Aspen Pharmacare Price Performance

The firm's 50-day moving average is $6.39 and its two-hundred day moving average is $7.31. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.25 and a current ratio of 2.35.

About Aspen Pharmacare

(Get Free Report)

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand.

Further Reading

Should You Invest $1,000 in Aspen Pharmacare Right Now?

Before you consider Aspen Pharmacare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Pharmacare wasn't on the list.

While Aspen Pharmacare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.